HUTCHMED (China) Limited
HCM
$17.93
$1.569.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.16% | -9.16% | -3.60% | -3.60% | -14.90% |
| Total Other Revenue | -- | -- | 21.10% | 21.10% | -21.10% |
| Total Revenue | -9.16% | -9.16% | 6.36% | 6.36% | -42.64% |
| Cost of Revenue | -6.97% | -6.97% | -20.34% | -20.34% | -13.53% |
| Gross Profit | -12.30% | -12.30% | 67.43% | 67.43% | -61.32% |
| SG&A Expenses | -28.00% | -28.00% | -15.11% | -15.11% | -15.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.61% | -15.61% | -14.48% | -14.48% | -20.90% |
| Operating Income | 87.23% | 87.23% | 82.65% | 82.65% | -124.65% |
| Income Before Tax | 1,685.54% | 1,685.54% | 124.49% | 124.49% | -83.13% |
| Income Tax Expenses | 2,088.57% | 2,088.57% | 142.05% | 142.05% | 5.71% |
| Earnings from Continuing Operations | 1,641.09% | 1,641.09% | 117.56% | 117.56% | -84.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -65.11% | -65.11% | -112.77% | -112.77% | 60.31% |
| Net Income | 1,663.32% | 1,663.32% | 117.60% | 117.60% | -84.69% |
| EBIT | 87.23% | 87.23% | 82.65% | 82.65% | -124.65% |
| EBITDA | 112.24% | 112.24% | 88.64% | 88.64% | -118.42% |
| EPS Basic | 1,657.62% | 1,657.62% | 117.59% | 117.59% | -84.82% |
| Normalized Basic EPS | 41.35% | 41.35% | 135.16% | 135.16% | -83.49% |
| EPS Diluted | 1,633.33% | 1,633.33% | 112.56% | 112.56% | -84.21% |
| Normalized Diluted EPS | 41.18% | 41.18% | 134.25% | 134.25% | -83.41% |
| Average Basic Shares Outstanding | 0.12% | 0.12% | 0.27% | 0.27% | 1.07% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 2.43% | 2.43% | 0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |